Danish pharmaceutical company Novo Nordisk, Inc., and a joint venture led by Ivy Equities and LCOR in partnership with Intercontinental Real Estate Corp., announced a $215 million project to redevelop a 770,000-square-foot office building in the Princeton Forrestal Center in Plainsboro, N.J. The building will serve as the new U.S. headquarters for Novo Nordisk, which provides diabetes care products.